NEW YORK, NY / ACCESSWIRE / February 5, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.
EXC Shareholders Click Here: https://www.zlk.com/pslra-1/exelon-corporation-loss-form?prid=5419&wire=1
PTLA Shareholders Click Here: https://www.zlk.com/pslra-1/portola-pharmaceuticals-inc-loss-form?prid=5419&wire=1
QD Shareholders Click Here: https://www.zlk.com/pslra-1/qudian-inc-loss-form?prid=5419&wire=1
* ADDITIONAL INFORMATION BELOW *
Exelon Corporation (NYSE:EXC)
EXC Lawsuit on behalf of: investors who purchased February 9, 2019 - November 1, 2019
Lead Plaintiff Deadline : February 14, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/exelon-corporation-loss-form?prid=5419&wire=1
According to the filed complaint, during the class period, Exelon Corporation made materially false and/or misleading statements and/or failed to disclose that: (i) Exelon and/or its employees were engaged in unlawful lobbying activities; (ii) the foregoing increased the risk of a criminal investigation into Exelon; (iii) Exelon subsidiary Commonwealth Edison's revenues were in part the product of unlawful conduct and thus unsustainable; and (iv) that, as a result, the Company's public statements were materially false and misleading at all relevant times.
Portola Pharmaceuticals, Inc. (NASDAQ:PTLA)
PTLA Lawsuit on behalf of: investors who purchased November 5, 2019 - January 9, 2020
Lead Plaintiff Deadline : March 16, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/portola-pharmaceuticals-inc-loss-form?prid=5419&wire=1
According to the filed complaint, during the class period, Portola Pharmaceuticals, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Portola's internal control over financial reporting regarding reserve for product returns was not effective; (2) Portola was shipping longer-dated product with 36-month shelf life; (3) Portola had not established adequate reserve for returns of prior shipments of short-dated product; (4) as a result, Portola was reasonably likely to need to "catch up" on accounting for return reserves; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Qudian Inc. (NYSE:QD)
QD Lawsuit on behalf of: investors who purchased December 13, 2018 - January 15, 2020
Lead Plaintiff Deadline : March 23, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/qudian-inc-loss-form?prid=5419&wire=1
According to the filed complaint, during the class period, Qudian Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) regulatory developments in China threatened to negatively impact Qudian's fiscal full year 2019 ("FY19") financial results; (ii) Qudian's business was unprepared to mitigate the risks associated with these regulatory changes; (iii) as a result, Qudian's loan portfolio was plagued by growing delinquency rates; (iv) all of the foregoing made Qudian's repeated assertions concerning its FY19 financial guidance unrealistic; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.
You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com
SOURCE: Levi & Korsinsky, LLP